- Presentations by top NHLBI SBIR-funded companies with innovative technologies on the brink of commercialization
- Expert panel of investors
- Opportunities for partnering and networking
July – November 2014
Please join us for an evening of networking and cocktails with your industry colleagues at Vino in Hollywood, FL. Meet Warren Marcus and colleagues of Altor BioScience; share thoughts, ideas and contacts; or simply connect with new and seasoned professionals in the life sciences industry!
5:30 – 6:00 pm
Please note: There is a $10 additional fee to register onsite. Please register in advance!
6:00 – 6:30 pm
6:30 – 6:45 pm
Welcome & Opening Remarks
6:45 – 7:15 pm
Warren Marcus, PhD, Research & Development Scientist/Business Development Associate, Altor BioScience Corporation
Altor BioScience is a venture-backed, privately-held, clinical-stage biopharmaceutical company developing breakthrough immunotherapeutic products based on its multiple proprietary technology platforms for the treatment of cancer, viral infections and autoimmune diseases. Warren received his Bachelor’s in Mechanical Engineering from MIT and his PhD in Cellular and Biosurface Engineering from Duke University. He is currently involved in all partnering activities related to Altor’s tissue factor antagonist antibody, ALT-836. He was also involved in the creation and preclinical testing of ALT-801 and ALT 803, two of Altor’s lead compounds currently undergoing clinical trials.
7:15 – 7:30 pm
Informal Panel Discussion:
“How Did You Get Here?”
-Warren Marcus, PhD, R&D Scientist/Business Development Associate, Altor BioScience Corporation
-Ebony Daniels Sanon, Biomedical/Quality Engineer, BioTeknica Engineering & Regulatory Services
-Nicholas Gonzalez, Quality Engineer, Beckman Coulter
7:30 – 7:45 pm
Q&A, Audience Share Experiences
7:45 – 8:00 pm
Closing Remarks & Additional Networking
The online Registration system is temporarily closed. To register for this event and to reserve your spot, please email firstname.lastname@example.org or email@example.com or call 561-653-3839 or 561-512-9888. Please have a credit card ready to submit when calling in.
$25 BioFlorida Members
$10 additional fee to Register onsite at the venue!
Health Connect South was created to build a first-of-its-kind sustainable platform for regional health collaborations. Though Georgia is home to world-class health assets, there is surprisingly little interdisciplinary clarity around areas of focus, impact, needs and capacity within and among our health assets. We believe such heightened clarity accelerates new opportunities for geographically advantaged collaborations, unlocking and advancing important advances in health.
Starting September 2014, Health Connect South will host an annual platform event centered around highlighting challenges and opportunities throughout our healthcare ecosystem. Creating the right “tone” and “texture” for this gathering will be critical. We are specifically looking to attract the leading innovators, decision-makers and top-tier students. Invited individuals will represent groups of investors, inventors, academics, clinicians, entrepreneurs, economic developers, NGO’s and other key health interests.
For more information, please visit Health Connect South’s website
NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts this semi-annual Regional Innovation Conference that brings together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries. NHLBI staff will be available to describe the details and impact of recent changes in the Federal SBIR/STTR program, as well as other funding opportunities and resources for small businesses.
Previous conferences have been held in Boston, MA, San Francisco, CA, San Diego, CA, and Rockville, MD.
Please see our Agenda & Speaker Page
Registration & Cost:
Registration is free, however space is limited. Priority registration is given to our selected showcase companies, Angel Capital Investors, Venture Capital investors, and Strategic Partners in the Southeast Region.
AdvaMed 2014 is the leading MedTech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2013 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more.
GaBio Member Discount Code: GABIO20 use this link to register
For more information and to register, please visit: AdvaMed2014
BioFlorida’s 17th annual Conference is the premier event for Florida’s bioscience community. This year’s meeting will bring together 500+ professionals from across Florida, the Southeast and the nation to discuss major trends and issues, including topics related to product development, scientific research, business development, financing and public policy.
For further information, please visit: http://bioflorida.com/displaycommon.cfm?an=1&subarticlenbr=35
The Georgia Life Sciences Summit has become a premier bioscience conference in the Southeast welcoming nearly 600 CEOs, senior executives, scientists and public policy officials from Georgia and across the nation. It is the one-time each year academia, industry and government come together to showcase Georgia’s leadership in innovation, from basic research to manufacturing, to improve the health and well-being of people, animals and the environment.
For more information and to register, please visit the conference website.
Device manufacturers, biodesign innovators, regulatory specialists, and academics are invited to the 2nd annual UGA Medical Device Regulations Conference! This conference, cosponsored by the US FDA and the University of Georgia’s Office of BioPharma Regulatory Affairs, will provide educational and networking opportunities to help shape the future of medical device advancement from a regulatory science perspective.
Registration and more information forthcoming.
The Southeast BIO (SEBIO) Investor & Partnering Forum provides an unparalleled opportunity for companies to meet key decision makers in the regional and national life science and medical technology communities.
Over 16 years, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country. We expect another sensational event in 2014 that will provide new opportunities to build business partnerships and explore the region’s burgeoning life science industry.
We expect about 350 biotech and medtech investors, corporate executives, university representatives, entrepreneurs and service providers to attend the event. This is a perfect opportunity to showcase your company’s products and services at the most significant annual life science event in the Southeast.
To date, the more than 200 later stage and 165 early stage companies that participated in previous SEBIO Investor & Partnering Forums have raised more than $2.5 billion in public and private funding since their presentations. These numbers speak to the quality of our presenting companies. In addition, our BIO/Plan Competition has successfully mentored 65 emerging technology opportunities.
Georgia’s life sciences community is a rich mix of companies applying life sciences technologies to improve medicine and healthcare, agriculture, industrial and energy production, forestry, marine science and environmental management. These companies range from established to start-up and from pharmaceutical to medical device and diagnostic to medical informatics companies. The state’s life sciences industry is anchored by world-class public and private research institutions and universities, including Emory University, the Georgia Institute of Technology and the University of Georgia. The U.S. Centers for Disease Control and Prevention, the premier public health research institute in the world, is headquartered in Atlanta. Georgia’s state government, through the Georgia Research Alliance and Georgia Cancer Coalition, has invested hundreds of millions of dollars in the state’s universities to support scientists in pursuit of basic research discoveries and early commercialization of technologies. These factors combined with a business-friendly environment provide a comprehensive ecosystem for life sciences companies to thrive in Georgia.
For more information and to register, please visit the conference site.